Merck & Co. Other Investing increased by 233.3% to $172.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 201.8%, from $57.00M to $172.00M. Over 3 years (FY 2021 to FY 2025), Other Investing shows a downward trend with a -13.9% CAGR.
Generally neutral, but large fluctuations may indicate non-recurring events or specific financial adjustments that warrant further investigation.
This metric aggregates miscellaneous cash inflows and outflows related to investing activities that do not fit into stan...
Usually a small component of total investing cash flow; peers report similar miscellaneous items based on specific accounting treatments.
cf_other_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00M | $1.00M | $106.00M | -$182.00M | -$12.00M | $45.00M | -$37.00M | $33.00M | $19.00M | $21.00M | $14.00M | $289.00M | -$233.00M | $57.00M | $20.00M | -$5.00M | -$129.00M | $172.00M |
| QoQ Change | — | -88.9% | >999% | -271.7% | +93.4% | +475.0% | -182.2% | +189.2% | -42.4% | +10.5% | -33.3% | >999% | -180.6% | +124.5% | -64.9% | -125.0% | <-999% | +233.3% |
| YoY Change | — | — | — | — | -233.3% | >999% | +79.7% | +375.0% | -57.8% | — | +137.8% | +775.8% | <-999% | +171.4% | +42.9% | -101.7% | +44.6% | +201.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.